Back to search

Boston University

Potential of utilizing specific miRNAs as biomarkers for polycystic ovarian syndrome (PCOS)

Abstract

dc:description.abstract

Polycystic Ovarian Syndrome is the one of the leading causes of infertility among women who are of child-bearing age. The syndrome’s vast range of phenotypes has made it challenging for researchers to not only consistently diagnose but also discover a cure. Currently, there are several proposed treatments being looked into, however, much of the research focuses on employing promising biomarkers, micro ribonucleic acids (miRNAs), that can potentially aid in diagnosis. The four prominent locations of research for these biomarkers include: ovarian tissues specifically looking into granulosa cells (GC), adipose tissue, follicular fluid, and the serum. My goal is to determine which of these areas holds the most promise to diagnose this syndrome in the years to come. This study reviewed a large collection of the current polycystic ovarian syndrome literature evaluating both reported miRNAs and how viable those would be as potential biomarkers to use for the future. The data showed that a majority of these promising biomarkers were found in granulosa cells, adipose tissue, and follicular fluid. Although there were miRNAs that were deemed promising in the serum, research is still far from conclusive in using these miRNAs as biomarkers for diagnosis of polycystic ovarian syndrome. By comparing the miRNAs selected from each type of location, I was able to conclude that miR-21, miR-93, miR-223, and miR-let-7b hold the most promise for the potential to become biomarkers for polycystic ovarian syndrome in the near future. Currently, there is a lot of research particularly surrounding these miRNAs and how they were shown to have been expressed in statistically significant levels among women with the syndrome. However, because of their complexity, miRNAs do not regulate one single pathway, it is hard to describe a mechanism that explains the pathophysiology of the syndrome. I believe we are still far away from successfully zooming in on one biomarker. By determining the most potential biomarker(s), we can focus resources and efforts towards finding a better diagnostic tool for this syndrome.

Degree

thesis:*
Name thesis:degree_name
Master of Science
Level thesis:degree_level
masters
Discipline thesis:degree_discipline
Medical Sciences
Grantor
Boston University
Year dc:date.issued
2020

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Rampally, Neha
Advisors dc:contributor.advisor
  • Levy, Simon
  • Adkins, Amy
ORCID dc:identifier.orcid

Subjects

dc:subject × 4

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/42186

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Rampally, Neha. Potential of utilizing specific miRNAs as biomarkers for polycystic ovarian syndrome (PCOS). masters thesis, Boston University, 2020. https://hdl.handle.net/2144/42186